Hepatitis B is a liver infection caused by the hepatitis B virus (HBV). Treatment can slow the progression of cirrhosis, reduce incidence of liver cancer and improve long term survival. Most people who start hepatitis B treatment must continue it for life. The product is intended for use as an aid in the management of HBV-infected individuals undergoing antiviral therapy, together with patient’s clinical data and other laboratory test results. HBV ELITe MGB® Kit is a quantitative nucleic acids amplification assay for the detection and the quantification of the DNA of Hepatitis B Virus (HBV) in DNA samples extracted from clinical specimens. The assay is able to detect the DNA of HBV belonging to genotypes A, B, C, D, E, F, G, H, I and RF. The assay is validated in association with ELITe InGenius® starting from human plasma collected in EDTA or in ACD and serum samples.
Benefits
Conserved targets -
Polymerase gene -TP domain
Internal Control: plasmid DNA with the artificial sequence
Easy-to-use -
Monoreagents, ready to use (Master Mix, standards curve and controls)
Best-in class PCR technology
-
ELITe MGB® probes designed with Minor Groove Binder technology, Superbases® and Eclipse® Dark Quencher
Integrated workflow -
Fully automated process for extraction, amplification and result analysis with ELITe InGenius
Limit of detection: 9IU/ml – 38copies/ml
Eluate storage -
Additional testing including multiple PCR from the same eluate, retesting or archiving
Minimal hands-on time -
Less than 2 minutes per sample from extraction to result analysis